Literature DB >> 9677128

Targeting IgE with monoclonal antibodies: the future is now.

J V Fahy, H A Boushey.   

Abstract

Mesh：

Substances：

Year:  1998        PMID： 9677128     DOI： 10.1046/j.1365-2222.1998.00290.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN： 0954-7894            Impact factor:   5.018


× No keyword cloud information.
  1 in total

Review 1.  Omalizumab: Anti-IgE therapy in allergy.

Authors:  Matthias Volkmar Kopp
Journal:  Curr Allergy Asthma Rep       Date:  2011-04       Impact factor: 4.806
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.